Developing a Strategy for Container and Closure Integrity –The Value of USP Guidance
Posted on March 4, 2016
By: Donald C. Singer, Global Lead Quality Manager, Microbiology R&D
GlaxoSmithKline
Developing a sterility assurance strategy includes the materials, process and evaluation of packaging used with the sterile product. Thus, package integrity is built into the sterility assurance strategy. The integration of quality and package design integrity is all about process and component unde...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Related Topics and Keywords
Container and Closure Integrity, Donald C. Singer, GlaxoSmithKline, quality and package design integrity, sterile product, sterility assurance strategy
Related Products
Clinical Supply Services for the Asia-Pacific Region - Catalent Pharma Solutions
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy
